Bruno Lopes Abbadi

586 total citations
27 papers, 358 citations indexed

About

Bruno Lopes Abbadi is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Bruno Lopes Abbadi has authored 27 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 19 papers in Molecular Biology and 15 papers in Epidemiology. Recurrent topics in Bruno Lopes Abbadi's work include Tuberculosis Research and Epidemiology (20 papers), Cancer therapeutics and mechanisms (11 papers) and Mycobacterium research and diagnosis (8 papers). Bruno Lopes Abbadi is often cited by papers focused on Tuberculosis Research and Epidemiology (20 papers), Cancer therapeutics and mechanisms (11 papers) and Mycobacterium research and diagnosis (8 papers). Bruno Lopes Abbadi collaborates with scholars based in Brazil, France and Spain. Bruno Lopes Abbadi's co-authors include Luiz Augusto Basso, Pablo Machado, Cristiano Valim Bizarro, Anne Drumond Villela, Valnês S. Rodrigues-Junior, Kenia Pissinate, Diógenes Santiago Santos, Maria M. Campos, Nathalia Sperotto and Raoní Scheibler Rambo and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Bruno Lopes Abbadi

26 papers receiving 354 citations

Peers

Countries citing papers authored by Bruno Lopes Abbadi

Since Specialization

Citations

This map shows the geographic impact of Bruno Lopes Abbadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Lopes Abbadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Lopes Abbadi more than expected).

Fields of papers citing papers by Bruno Lopes Abbadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Lopes Abbadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Lopes Abbadi. The network helps show where Bruno Lopes Abbadi may publish in the future.

Co-authorship network of co-authors of Bruno Lopes Abbadi

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Lopes Abbadi. A scholar is included among the top collaborators of Bruno Lopes Abbadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Lopes Abbadi. Bruno Lopes Abbadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments 2022 ·Journal of Computer-Aided Molecular Design ·(unknown), (unknown), Bruno Lopes Abbadi, (unknown), (unknown), (unknown), (unknown), (unknown), Pablo Machado, Cristiano Valim Bizarro, Luiz Augusto Basso, Luís Fernando Saraiva Macedo Timmers	4
2	Viral isolation allows characterization of early samples of SARS-CoV-2 lineage B1.1.33 with unique mutations (S: H655Y and T63N) circulating in Southern Brazil in 2020 2022 ·Brazilian Journal of Microbiology ·Juliana Schons Gularte, (unknown), (unknown), Meriane Demoliner, (unknown), Alana Witt Hansen, (unknown), Fágner Henrique Heldt, Viviane Girardi, Matheus Nunes Weber, Paula Rodrigues de Almeida, Bruno Lopes Abbadi, (unknown), Cristiano Valim Bizarro, Pablo Machado, Luiz Augusto Basso, Odir Antônio Dellagostin, Juliane Deise Fleck, Fernando Rosado Spilki	2
3	Evaluation of 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase (DAHPS) as a Vulnerable Target in Mycobacterium tuberculosis 2022 ·Microbiology Spectrum ·(unknown), (unknown), Bruno Lopes Abbadi, Nathalia Sperotto, (unknown), (unknown), (unknown), Letícia Beatriz Matter, (unknown), Tanya Parish, Pablo Machado, Luiz Augusto Basso, Cristiano Valim Bizarro	2
4	8-Mercaptoguanine-based inhibitors of Mycobacterium tuberculosis dihydroneopterin aldolase: synthesis, in vitro inhibition and docking studies 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown), (unknown), Rodrigo G. Ducati, Kenia Pissinate, Raoní Scheibler Rambo, Luís Fernando Saraiva Macedo Timmers, Bruno Lopes Abbadi, (unknown), (unknown), Luiz Augusto Basso, Pablo Machado, Cristiano Valim Bizarro	1
5	Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosis 2021 ·Tuberculosis ·(unknown), (unknown), Bruno Lopes Abbadi, (unknown), (unknown), (unknown), Teresa Dalla Costa, (unknown), Samuel Paulo Cibulski, Cristiano Valim Bizarro, Pablo Machado, Luiz Augusto Basso, Valnês S. Rodrigues-Junior	10
6	Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Bruno Lopes Abbadi, (unknown), Nathalia Sperotto, Kenia Pissinate, Raoní Scheibler Rambo, (unknown), Diana Machado, Miguel Viveiros, Cristiano Valim Bizarro, Luiz Augusto Basso, Pablo Machado	44
7	Pentacyanoferrate(II) complex of pyridine-4- and pyrazine-2-hydroxamic acid as source of HNO: investigation of anti-tubercular and vasodilation activities 2020 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown), Tércio de F. Paulo, Alix Sournia‐Saquet, Bruno Lopes Abbadi, (unknown), Cristiano Valim Bizarro, (unknown), (unknown), Nilberto Robson Falcão do Nascimento, Luiz Gonzaga de França Lopes, Rémi Chauvin, Eduardo Henrique Silva Sousa, Vania Bernardes‐Génisson	10
8	Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Bruno Lopes Abbadi, Anne Drumond Villela, (unknown), Luiz Cláudio Rodrigues Pereira da Silva, Pablo Machado, Cristiano Valim Bizarro, Luiz Augusto Basso, Marcela Cristina de Moraes, Vı́tor F. Ferreira, Fernando de Carvalho da Silva, Vanessa Nascimento	20
9	Handling the Hurdles on the Way to Anti-tuberculosis Drug Development 2020 ·Frontiers in Chemistry ·(unknown), (unknown), Bruno Lopes Abbadi, (unknown), Raoní Scheibler Rambo, (unknown), (unknown), Pablo Machado, Cristiano Valim Bizarro, Luiz Augusto Basso	25
10	Synthesis and photophysical, thermal and antimycobacterial properties of novel 6-amino-2-alkyl(aryl/heteroaryl)-4-(trifluoromethyl) quinolines 2019 ·New Journal of Chemistry ·(unknown), (unknown), (unknown), Paulo R. S. Salbego, Thiago V. Acunha, Bruno Lopes Abbadi, Cristiano Valim Bizarro, Luiz Augusto Basso, Pablo Machado, Marcos A. P. Martins, Nilo Zanatta, Bernardo A. Iglesias, Hélio G. Bonacorso	17
11	Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy 2019 ·Regulatory Toxicology and Pharmacology ·Valnês S. Rodrigues-Junior, Anne Drumond Villela, Bruno Lopes Abbadi, Nathalia Sperotto, Kenia Pissinate, Jaqueline Nascimento Picada, (unknown), Cristiano Valim Bizarro, Pablo Machado, Luiz Augusto Basso	13
12	Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis? 2018 ·Frontiers in Microbiology ·Bruno Lopes Abbadi, Valnês S. Rodrigues-Junior, (unknown), Kenia Pissinate, Anne Drumond Villela, Maria M. Campos, Luiz Gonzaga de França Lopes, Cristiano Valim Bizarro, Pablo Machado, Eduardo Henrique Silva Sousa, Luiz Augusto Basso	11
13	Assessing the role of deoD gene in Mycobacterium tuberculosis in vitro growth and macrophage infection 2018 ·Microbial Pathogenesis ·(unknown), Valnês S. Rodrigues-Junior, (unknown), Antônio F. M. Pinto, Bruno Lopes Abbadi, Cristiano Valim Bizarro, Luiz Augusto Basso, Anne Drumond Villela, Diógenes Santiago Santos	3
14	1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity 2018 ·European Journal of Medicinal Chemistry ·(unknown), Kenia Pissinate, Anne Drumond Villela, Bruno Lopes Abbadi, Valnês S. Rodrigues-Junior, Débora Dreher Nabinger, Stefani Altenhofen, Nathalia Sperotto, (unknown), Fernanda Teixeira Subtil, (unknown), (unknown), (unknown), Carla Denise Bonan, Cristiano Valim Bizarro, Luiz Augusto Basso, Diógenes Santiago Santos, Pablo Machado	24
15	Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing 2017 ·International Journal of Antimicrobial Agents ·Fernanda Teixeira Subtil, Anne Drumond Villela, Bruno Lopes Abbadi, Valnês S. Rodrigues-Junior, Cristiano Valim Bizarro, Luís Fernando Saraiva Macedo Timmers, Osmar Norberto de Souza, Kenia Pissinate, Pablo Machado, (unknown), Griselda Tudó, Julian González-Martín, Luiz Augusto Basso, Diógenes Santiago Santos	19
16	Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy 2017 ·Journal of Inorganic Biochemistry ·(unknown), Céline Deraeve, (unknown), Alix Sournia‐Saquet, Lionel Rechignat, Anne Drumond Villela, Bruno Lopes Abbadi, (unknown), Kenia Pissinate, Cristiano Valim Bizarro, Pablo Machado, Luiz Augusto Basso, Geneviève Pratviel, Luiz Gonzaga de França Lopes, Eduardo Henrique Silva Sousa, Vania Bernardes‐Génisson	17
17	Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme 2017 ·Scientific Reports ·Leonardo Martinelli, (unknown), Anne Drumond Villela, Valnês S. Rodrigues-Junior, Bruno Lopes Abbadi, (unknown), (unknown), (unknown), Laura Roesler Nery, Ivaní Pauli, Maria M. Campos, Carla Denise Bonan, Osmar Norberto de Souza, Luiz Augusto Basso, Diógenes Santiago Santos	12
18	New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis 2016 ·European Journal of Medicinal Chemistry ·(unknown), Kenia Pissinate, Valnês S. Rodrigues-Junior, Anne Drumond Villela, (unknown), Bruno Lopes Abbadi, Fernanda Teixeira Subtil, Nathalia Sperotto, (unknown), Davi F. Back, Maria M. Campos, Luiz Augusto Basso, Pablo Machado, Diógenes Santiago Santos	34
19	Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection 2016 ·International Journal of Antimicrobial Agents ·Valnês S. Rodrigues-Junior, Anne Drumond Villela, Raoni S. B. Gonçalves, Bruno Lopes Abbadi, (unknown), (unknown), Griselda Tudó, Julian González-Martín, Luiz Augusto Basso, M.V.N. De Souza, Maria M. Campos, Diógenes Santiago Santos	19
20	Mode of action of recombinant hypoxanthine–guanine phosphoribosyltransferase from Mycobacterium tuberculosis 2015 ·RSC Advances ·(unknown), Leonardo Martinelli, (unknown), Bruno Lopes Abbadi, Diógenes Santiago Santos, Luiz Augusto Basso	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact